The Utility of Estrogen Receptor and Progesterone Receptor Immunohistochemistry in the Distinction of Metastatic Breast Carcinoma from other Tumors in the Liver

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 12, 2003, Pages 1591-1595

  Nash, Jason W ^a   Morrison, Carl ^a   Frankel, Wendy L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b E 401 Doan Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BILE DUCT CARCINOMA; BREAST CARCINOMA; BREAST METASTASIS; CANCER GRADING; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; ESOPHAGUS METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; STOMACH;

ADENOCARCINOMA; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0344305655     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Molteni A, Bahu RM, Battifora HA, et al. Estradiol receptor assays in normal and neoplastic tissues: a possible diagnostic acid for tumor differentiation. Ann Clin Lab Sci. 1979;9:103-108.
2. Enmark E, Gustafsson JA. Oestrogen receptors: an overview. J Intern Med. 1999;246:133-138.
3. Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol. 2002;11:487-502.
4. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen receptor-alpha distribution in the human hypothalamus in relation to sex and endocrine status. J Comp Neurol. 2002;454:115-139.
5. Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg. 1995;82:542-547.
6. Kvasha MS, Zakhartsev LM. Estrogen and progesterone receptors in cerebral meningioma and their clinical value. Klin Khir. 2002;8:50-52.
7. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions. Pol J Pathol. 2002;53:67-72.
8. Radzikowska E, Langfort R, Giedronowicz D. Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2002;8:69-73.
9. Yeh TS, Jan YY, Chiu CT, et al. Characterization of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma. Gut. 2002;51:712-716.
10. Francavilla A, Di Leo A, Polimeno L, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology. 1987;93:1301-1306.
11. Linsalata M, Messa C, Russo F, Cavallini A, Di Leo A. Estrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol. 1994; 29:67-70.
12. Yokozaki H, Takekura N, Takanashi A, Tabuchi J, Haruta R, Tahara E. Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis. Virchows Arch A Pathol Anat Histopathol. 1988;413:297-302.
13. Daniei SJ, Nader R, Kost K, Huttner I. Facial sweat gland carcinoma metastasizing to neck nodes: a diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg. 2001;127:1495-1498.
14. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol. 1999;12:786-793.
15. Kaklamanos IG, Bathe OF, Franceschi D, et al. Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival. J Surg Oncol. 1999;72:225-229.
16. Dahmoun M, Backstrom T, Boman K, Cajander S. Apoptosis, proliferation, and hormone receptors in endometrial carcinoma: results depending on methods of analysis. Int J Oncol. 2003;22:115-122.
17. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology. 2002;143:4172-4177.
18. Bejar J, Sabo E, Eldar S, Lev M, Misselevich I, Boss JH. The prognostic significance of the semiquantitatively determined estrogen receptor content of breast carcinomas: a clinicopathological study. Pathol Res Pract. 2002;198:455-460.
19. Lamy PJ, Pujol P, Thezenas S, et al. Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy. Breast Cancer Res Treat. 2002;76:65-71.
20. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology. 1996; 29:233-240.
21. Kaufmann O, Kother S, Dietel M. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods. Mod Pathol. 1998;11:357-363.
22. Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: a diagnostic adjunct in the determination of primary site. Am J Clin Pathol. 1997:12-19.
23. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol. 1997;28:938-943.
24. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002; 73:403-405.
25. Lee BH, Hecht JL, Pinkus JL, Pinkus GS. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol. 2002;117:745-750.
26. Raab SS, Berg LC, Swanson PE, Wick MR. Adenocarcinoma in the lung in patients with breast cancer: a prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol. 1993;100:27-35.